PRTGPORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 4.68 $ 0.61 (15.56 %)    

Tuesday, 17-Sep-2024 15:30:01 EDT
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ 4.53
$ 3.83
-- x --
-- x --
$ 3.83 - $ 4.74
$ 2.10 - $ 59.13
101,886
na
4.48M
$ 37.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 portage-biotech-continues-to-explore-strategic-alternatives-including-potential-sale-merger-restructuring-or-company-wind-down

- Reuters 

 portage-biotech-q2-eps-158-up-from-669-yoy

Portage Biotech (NASDAQ:PRTG) reported quarterly losses of $(1.58) per share. This is a 76.38 percent increase over losses of $...

 portage-biotech-reports-fy24-net-result-of-754m-vs-1047m-last-year-says-discontinuing-inkt-clinical-trial-for-port-2-continues-to-explore-strategic-alternatives-including-restructurings-both-in-and-out-of-court

The decrease was primarily due to lower non-cash losses on impairment related to the Company's identifiable intangible asse...

 why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION